12:00 AM
 | 
Jan 04, 2000
 |  BC Week In Review  |  Company News  |  Deals

Genome Therapeutics, Wyeth-Ayerst deal

The companies will combine GENE's bioinformatics and genomics technologies with Wyeth's expertise in bone biology to...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >